Clover Health Investments (CLOV) Delivers Strong Revenue Growth in Q4 2025 Amid Path to Profitability

Stock chart and financial data overlay for Clover Health Investments (CLOV) Q4 2025 earnings release

“Clover Health reported Q4 2025 total revenues of approximately $488 million, marking a roughly 45% year-over-year increase and surpassing analyst expectations. The company posted a GAAP net loss but achieved full-year Adjusted EBITDA profitability of $22 million for 2025, with Medicare Advantage membership climbing 38% to over 113,000. Despite ongoing industry cost pressures, medical trends … Read more

Kimberly-Clark Reports Strong Finish to Second Year of Transformation

Kimberly-Clark corporate headquarters building with logo

“Kimberly-Clark capped off the second year of its major transformation with robust fourth-quarter results, featuring a 24% rise in adjusted earnings per share to $1.86, alongside 2.1% organic sales growth. Full-year net sales reached $16.4 billion with 1.7% organic growth, while adjusted EPS climbed to $7.53. The company highlighted momentum from its Powering Care strategy, … Read more